Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$916,493,106
-$106,259,087 QoQ
Shares Held
38,060,345
+4.5% QoQ
Ownership
0.668%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#17
of 2,812 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 80%
Shared 11%
None 9%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $19,386,650,383 across 15 Drug Manufacturers - General names. PFE ranks #9 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,003,417 | $4,801,818,850 | |
| 2 | JNJ |
Johnson & Johnson
|
15,385,556 | $3,907,469,656 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,486,486 | $2,247,013,450 | |
| 4 | ABBV |
AbbVie Inc.
|
7,236,861 | $1,821,083,699 | |
| 5 | NVS |
Novartis AG
|
8,117,586 | $1,272,188,077 | |
| 6 | AMGN |
Amgen Inc
|
3,413,981 | $1,236,270,798 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
19,691,951 | $1,134,650,214 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
7,899,794 | $998,059,971 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $916,493,106 | 38,060,345 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,022,752,193 | 36,422,799 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $899,631,270 | 36,129,770 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $925,829,328 | 36,335,531 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $842,495,473 | 34,756,414 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $743,127,121 | 29,326,248 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $776,381,294 | 29,264,278 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $966,333,598 | 33,390,933 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $932,261,590 | 33,318,856 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $990,393,059 | 35,689,840 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,208,442,601 | 41,974,387 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,500,588,639 | 45,239,332 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,724,049,241 | 47,002,433 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,780,727,380 | 43,645,279 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,157,456,047 | 42,104,919 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,804,768,035 | 41,242,414 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,109,416,974 | 40,233,015 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,013,943,235 | 38,901,743 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,315,610,320 | 39,214,400 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,701,246,786 | 39,554,680 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,560,251,645 | 39,842,994 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,444,210,984 | 39,862,296 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,503,259,737 | 40,838,352 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $1,561,016,041 | 42,534,539 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,577,997,290 | 48,256,748 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,590,287,516 | 48,722,110 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||